Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BFLY Butterfly Network	$7.69 +5.8%	$5.06	$1.32 ▼ $8.94	$1.85B	2.22	8.81 million shs	12.74 million shs
KIDS OrthoPediatrics	$18.38 +1.2%	$17.47	$14.42 ▼ $23.70	$466.44M	1.03	110,602 shs	130,394 shs
NVCR NovoCure	$14.13 +3.8%	$15.73	$9.82 ▼ $18.92	$1.58B	0.93	1.65 million shs	1.75 million shs
PLSE Pulse Biosciences	$25.95 +0.9%	$23.79	$12.56 ▼ $28.53	$1.78B	1.65	283,639 shs	180,052 shs

The 10 Best High-Yield Dividend Stocks for 2026

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BFLY Butterfly Network	+5.85%	+36.83%	+72.00%	+83.80%	+275.12%
KIDS OrthoPediatrics	+1.21%	-0.81%	+0.05%	+13.25%	-10.73%
NVCR NovoCure	+3.82%	-19.21%	-21.33%	+21.71%	-14.93%
PLSE Pulse Biosciences	+0.93%	+3.35%	+0.23%	+17.85%	+67.53%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BFLY Butterfly Network	$7.69 +5.8%	$5.06	$1.32 ▼ $8.94	$1.85B	2.22	8.81 million shs	12.74 million shs
KIDS OrthoPediatrics	$18.38 +1.2%	$17.47	$14.42 ▼ $23.70	$466.44M	1.03	110,602 shs	130,394 shs
NVCR NovoCure	$14.13 +3.8%	$15.73	$9.82 ▼ $18.92	$1.58B	0.93	1.65 million shs	1.75 million shs
PLSE Pulse Biosciences	$25.95 +0.9%	$23.79	$12.56 ▼ $28.53	$1.78B	1.65	283,639 shs	180,052 shs

The 10 Best High-Yield Dividend Stocks for 2026

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BFLY Butterfly Network	+5.85%	+36.83%	+72.00%	+83.80%	+275.12%
KIDS OrthoPediatrics	+1.21%	-0.81%	+0.05%	+13.25%	-10.73%
NVCR NovoCure	+3.82%	-19.21%	-21.33%	+21.71%	-14.93%
PLSE Pulse Biosciences	+0.93%	+3.35%	+0.23%	+17.85%	+67.53%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BFLY Butterfly Network	2.33	Hold	$5.56	-27.67% Downside
KIDS OrthoPediatrics	2.73	Moderate Buy	$24.44	32.99% Upside
NVCR NovoCure	2.38	Hold	$26.86	90.07% Upside
PLSE Pulse Biosciences	2.50	Moderate Buy	$30.67	18.18% Upside

Current Analyst Ratings Breakdown

Latest KIDS, BFLY, PLSE, and NVCR Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
6/18/2026	NVCR NovoCure	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$48.00 ➝ $46.00
6/15/2026	KIDS OrthoPediatrics	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy
6/4/2026	PLSE Pulse Biosciences	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Buy	$32.00
6/1/2026	NVCR NovoCure	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
5/6/2026	BFLY Butterfly Network	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D-)
5/4/2026	NVCR NovoCure	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Equal Weight	$13.50 ➝ $17.00
5/1/2026	KIDS OrthoPediatrics	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$17.00
5/1/2026	NVCR NovoCure	Evercore Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Outperform
5/1/2026	KIDS OrthoPediatrics	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$24.00
4/24/2026	KIDS OrthoPediatrics	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$25.00
4/21/2026	KIDS OrthoPediatrics	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)

(Data available from 6/24/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BFLY Butterfly Network	$102.92M	19.03	N/A	N/A	$0.77 per share	9.99
KIDS OrthoPediatrics	$236.35M	2.00	$0.17 per share	109.21	$13.82 per share	1.33
NVCR NovoCure	$655.35M	2.50	N/A	N/A	$3.04 per share	4.65
PLSE Pulse Biosciences	$350K	5,131.43	N/A	N/A	$1.19 per share	21.81

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BFLY Butterfly Network	-$77.06M	-$0.30	N/A	N/A	N/A	-73.63%	-34.41%	-23.91%	7/31/2026 (Estimated)
KIDS OrthoPediatrics	-$39.65M	-$1.68	N/A	N/A	N/A	-16.31%	-7.01%	-4.86%	8/4/2026 (Estimated)
NVCR NovoCure	-$136.23M	-$1.53	N/A	N/A	N/A	-25.66%	-50.82%	-16.48%	7/23/2026 (Estimated)
PLSE Pulse Biosciences	-$72.78M	-$1.10	N/A	N/A	N/A	N/A	-86.67%	-73.61%	8/11/2026 (Estimated)

Latest KIDS, BFLY, PLSE, and NVCR Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
5/4/2026	Q1 2026	PLSE Pulse Biosciences	-$0.32	-$0.27	+$0.05	-$0.27	$0.25 million	$0.40 million
4/30/2026	Q1 2026	BFLY Butterfly Network	-$0.04	-$0.03	+$0.01	-$0.05	$26.08 million	$26.53 million
4/30/2026	Q1 2026	KIDS OrthoPediatrics	-$0.4552	-$0.42	+$0.0352	-$0.45	$58.29 million	$59.36 million
4/30/2026	Q1 2026	NVCR NovoCure	-$0.5122	-$0.62	-$0.1078	-$0.62	$167.77 million	$174.06 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
BFLY Butterfly Network	N/A	N/A	N/A	N/A	N/A
KIDS OrthoPediatrics	N/A	N/A	N/A	N/A	N/A
NVCR NovoCure	N/A	N/A	N/A	N/A	N/A
PLSE Pulse Biosciences	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BFLY Butterfly Network	N/A	4.02	3.03
KIDS OrthoPediatrics	0.29	5.21	2.37
NVCR NovoCure	0.71	2.90	2.70
PLSE Pulse Biosciences	N/A	7.26	7.24

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BFLY Butterfly Network	37.85%
KIDS OrthoPediatrics	69.05%
NVCR NovoCure	84.61%
PLSE Pulse Biosciences	76.95%

Insider Ownership

Company	Insider Ownership
BFLY Butterfly Network	21.99%
KIDS OrthoPediatrics	31.80%
NVCR NovoCure	5.52%
PLSE Pulse Biosciences	74.00%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BFLY Butterfly Network	460	254.63 million	198.64 million	Optionable
KIDS OrthoPediatrics	200	25.68 million	17.52 million	Optionable
NVCR NovoCure	1,605	115.82 million	109.43 million	Optionable
PLSE Pulse Biosciences	140	69.21 million	18.00 million	Optionable

KIDS, BFLY, PLSE, and NVCR Headlines

Recent News About These Companies

What Do Pulse Biosciences’ New Equity Awards Reveal About Executive Compensation Trends?

June 15, 2026 | kalkinemedia.comK

What Could New Equity Awards Signal for Pulse Biosciences’ Ongoing Growth Efforts?

June 15, 2026 | kalkinemedia.comK

Pulse Biosciences Shareholders Approve Board and Auditor Slate

June 12, 2026 | tipranks.com

Pulse Biosciences, Inc. (PLSE) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

June 10, 2026 | seekingalpha.com

Pulse Biosciences Updates 2026 Cardiac Ablation Strategy

June 10, 2026 | theglobeandmail.com

Pulse Bio to redeem remaining common stock warrants

June 10, 2026 | seekingalpha.com

Did New Analyst Coverage and Insider Buying Just Shift Pulse Biosciences' (PLSE) Investment Narrative?

June 9, 2026 | finance.yahoo.com

Pulse Biosciences to Present at the Goldman Sachs 47th Annual Global Healthcare Conference 2026

May 27, 2026 | businesswire.com

Here's Why Pulse Biosciences, Inc (PLSE) is a Great Momentum Stock to Buy

May 26, 2026 | zacks.com

Why Pulse Biosciences, Inc.’s (PLSE) Stock Is Down 6.55%

May 16, 2026 | aaii.comA

Pulse Biosciences, Inc. (PLSE) Presents at Bank of America Global Healthcare Conference 2026 Prepared Remarks Transcript

May 13, 2026 | seekingalpha.com

Pulse Biosciences, Inc. (PLSE) Presents at Bank of America Global Healthcare Conference 2026 - Slideshow

May 13, 2026 | seekingalpha.com

Pulse Biosciences (NASDAQ:PLSE) CEO Acquires $295,350.00 in Stock

May 12, 2026 | insidertrades.com

Pulse Biosciences Authorizes Insider Purchases Under Equity Program

May 11, 2026 | theglobeandmail.com

Is Pulse Biosciences (PLSE) Quietly Redefining Its Core Identity Around Atrial Fibrillation?

May 11, 2026 | finance.yahoo.com

PLSE Q1 2026 Earnings Transcript

May 8, 2026 | finance.yahoo.com

Pulse Biosciences to Present at the BofA Securities 2026 Healthcare Conference

May 8, 2026 | finance.yahoo.com

Pulse Biosciences, Inc. (PLSE) Q1 2026 Earnings Call Transcript

May 8, 2026 | seekingalpha.com

Pulse Biosciences (PLSE) Upgraded to Buy: What Does It Mean for the Stock?

May 7, 2026 | zacks.com

Pulse Biosciences Reports Business Updates and First Quarter 2026 Financial Results

May 4, 2026 | finance.yahoo.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

KIDS, BFLY, PLSE, and NVCR Company Descriptions

Butterfly Network NYSE:BFLY

$7.69 +0.42 (+5.78%)

Closing price 06/23/2026 03:58 PM Eastern

Extended Trading

$7.78 +0.09 (+1.24%)

As of 07:27 AM Eastern

Butterfly Network, Inc. develops, manufactures, and commercializes ultrasound imaging solutions in the United States and internationally. It offers Butterfly iQ, a handheld and single-probe whole body ultrasound system; Butterfly iQ+ and iQ3 ultrasound devices that can perform whole-body imaging in a single handheld probe integrated with the clinical workflow, and accessible on a user's smartphone, tablet, and almost any hospital computer system; and Butterfly iQ+ Vet, a handheld ultrasound system designed for veterinarians. The company also provides Butterfly system, which includes probes, and related accessories and software subscriptions to healthcare systems, physicians, and healthcare providers through a direct sales force, distributors, and eCommerce channel. In addition, it offers cloud-based software solutions to healthcare systems, teleguidance, in-app educational tutorials, and formal education programs through its Butterfly Academy software, as well as professional services for large scale deployments; and ScanLab, an education-only app provides written walkthroughs and reference imagery to guide real-time educational scanning, enhancing the learning process. Butterfly Network, Inc. was founded in 2011 and is headquartered in Burlington, Massachusetts.

OrthoPediatrics NASDAQ:KIDS

$18.38 +0.22 (+1.21%)

Closing price 06/23/2026 04:00 PM Eastern

Extended Trading

$18.42 +0.05 (+0.24%)

As of 07:22 AM Eastern

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediguard, Pediatric Nailing Platform | Femur, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIMTM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIROTM Growth Modulation System, PNP Tibia System, ApiFix Mid-C System, and Mitchell Ponseti. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.

NovoCure NASDAQ:NVCR

$14.13 +0.52 (+3.82%)

Closing price 06/23/2026 04:00 PM Eastern

Extended Trading

$14.06 -0.08 (-0.53%)

As of 06:07 AM Eastern

NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, Japan, Greater China, and internationally. The company's TTFields devices include Optune Gio and Optune Lua. It also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Saint Helier, Jersey.

Pulse Biosciences NASDAQ:PLSE

$25.95 +0.24 (+0.93%)

Closing price 06/23/2026 04:00 PM Eastern

Extended Trading

$25.85 -0.10 (-0.40%)

As of 06:50 AM Eastern

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest KIDS, BFLY, PLSE, and NVCR Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest KIDS, BFLY, PLSE, and NVCR Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

KIDS, BFLY, PLSE, and NVCR Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

KIDS, BFLY, PLSE, and NVCR Company Descriptions

Butterfly Network NYSE:BFLY

OrthoPediatrics NASDAQ:KIDS

NovoCure NASDAQ:NVCR

Pulse Biosciences NASDAQ:PLSE

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest KIDS, BFLY, PLSE, and NVCR Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest KIDS, BFLY, PLSE, and NVCR Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

KIDS, BFLY, PLSE, and NVCR Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

KIDS, BFLY, PLSE, and NVCR Company Descriptions

Butterfly Network NYSE:BFLY

OrthoPediatrics NASDAQ:KIDS

NovoCure NASDAQ:NVCR

Pulse Biosciences NASDAQ:PLSE

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools